Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05962359 · ClinicalTrials.gov registry record · NA
Neural Prediction to Enhance Language
A NA study of Bilateral Sensorineural Hearing Loss and Social Communication, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 1
- Study location
NCT05962359: Recruiting NA study of Bilateral Sensorineural Hearing Loss and Social Communication, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT05962359 is a NA study of Bilateral Sensorineural Hearing Loss and Social Communication that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 700 participants, above the 110-participant average among 3 other Bilateral Sensorineural Hearing Loss trials with a reported enrollment target (536% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05962359, a NA study of Bilateral Sensorineural Hearing Loss and Social Communication, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
The language outcome of children receiving cochlear implantation to address bilateral sensorineural hearing loss is more variable than that of typical hearing children. The research is focused upon development of neural predictive models based upon brain imaging to forecast language after cochlear implantation on the individual child level. The long-term goal is improving children's language by using predictive models to enable a custom "predict to prescribe" approach to intervene with more effective behavioral therapy for children at risk to develop poorer language. The investigators previously developed models for short term language outcome of English-learning implanted children. The aims of this study are to 1. Develop models able to predict long term outcome for English- learning and Spanish-learning children; and 2. To evaluate whether English-learning children predicted to achieve lower language based on the investigators' previously constructed models can demonstrate significant gains from Parent Implemented Communication Treatment (PICT). PICT is an intensive parent education program about strategies to improve children's communication.
Primary Outcome
A standardized measure of auditory comprehension and expressive communication in children. Standard scores are obtained which are then translated to percentiles, and age equivalents. Higher standard scores indicate better performance.
Conditions Studied
Interventions
- BEHAVIORAL Parent-Implemented Communication Treatment
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2023-01-23 |
| Est. Completion | 2028-01-23 |
| Phase | NA |
What NCT05962359 shows while recruiting
NCT05962359 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 110-participant average among 3 other Bilateral Sensorineural Hearing Loss trials with a reported enrollment target (536% higher).
The record links to 3 conditions, with Bilateral Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Parent-Implemented Communication Treatment is the first listed.
NCT05962359 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05962359 about?
NCT05962359 is a clinical study titled "Neural Prediction to Enhance Language". The language outcome of children receiving cochlear implantation to address bilateral sensorineural hearing loss is more variable than that of typical hearing children. The research is focused upon development of neural predictive models based upon brain imaging to forecast language after cochlear i...
What is the current status of trial NCT05962359?
This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2023-01-23. Estimated completion is 2028-01-23.
What conditions does trial NCT05962359 study?
This clinical trial studies the following conditions: Bilateral Sensorineural Hearing Loss, Social Communication, Speech and Language Development Delay Due to Hearing Loss.
What interventions are being tested in trial NCT05962359?
The interventions under investigation include: Parent-Implemented Communication Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05962359?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05962359 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bilateral Sensorineural Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessing the Effect of Computer-based Auditory Training on Adult Cochlear Implant Speech and Quality-of-life Outcomes
RECRUITING · NA
-
Binaural Cue Sensitivity in Children and Adults With Combined Electric and Acoustic Stimulation
RECRUITING
-
Effect of Donepezil on Speech Recognition in Cochlear Implant Users
ACTIVE NOT RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI